A valid radioassay for the estimation of serum vitamin B 12 in the presence of naturally occurring vitamin B 1 2 ( = cobalamin) analogues can be operated if serum transcobalamin II (TC II) is used as the binding protein. Serum samples that gave diagnostically discrepant results when their vitamin B 12 content was analysed (i) by a commercial radioassay known to be susceptible to interference from cobalamin analogues, and (ii) by microbiological assay, were further analysed by an alternative radioassay which uses the transcobalamins (principally TC II) of diluted normal serum as the assay binding protein. Concordance between the results from microbiological assay and the TC II-based radioassay was found in all cases. In an extended study over a three-year period, all routine serum samples sent for vitamin B 12 analysis that had a vitamin B 12 content of less than 320 ngjl by the TC II-based radioassay (reference range 200-850 ngjl) were reanalysed using an established microbiological method. Over 1000 samples were thus analysed. The data are presented to demonstrate the validity of the TC II-based radioassay results in this group of patients, serum samples from which are most likely to produce diagnostically erroneous vitamin B 12 results when analysed by a radioassay that is less specific for cobalamins.
taminated with 51-85 % of non-specific 'R' binders;
(iii) 'R' binders complex both cobalamins and cobalamin analogues, so that radioassays using these binders measure the sum of both concentrations in serum; (iv) some patients who are vitamin B 1 2 deficient have sufficient cobalamin analogues in their serum for a radioassay based on 'R' binders to give an erroneously normal serum vitamin B 12 result.
Other authors have questioned this explanation of erroneous serum vitamin~2 results by radioassay" although no alternative mechanisms have been proposed. Like many others, our awareness of .this analytical problem started with a clear discrepancy between serum vitamin B 12 results produced using a commercial radio assay and the clinical diagnosis of certain patients. Portions of the questioned samples were sent to a second laboratory for re-analysis by an alternative radioassay based on the method of Tibbling.? This radioassay uses the transcobalamins of normal human serum, principally transcobalamin II (TC II), as the binding protein in contrast to the intrinsic factor-'R' binder mixture ofthe commercial kit. Results from this TC II-based radioassay were 287 §To whom all enquiries should be addressed.
Recent reports of serum vitamin B 12 analyses have shown a disturbing discrepancy between the clinical state of vitamin~2 deficiency in a number of patients and the normal result produced for their serum vitamin~2 concentrations by certain radioassay procedures.>" It is estimated that this discrepancy occurs in more than 10% of vitamin~2 deficient patients.' That the problem lay in the radioassays was clearly demonstrated by repeating the analyses using a microbiological method. 3 Patients who were clinically vitamin B 12 deficient had unquestionably low serum vitamin B 12 concentrations by microbiological assay, while the result given by radioassay was low-normal or borderline in 15 out of 45 cases.
Thorough investigation of this problem was performed by Kolhouse et al., 6 who concluded that (i) serum contains various amounts of cobalamin analogues which are physiologically inactive and whose existence was previously unsuspected; (ii) the binding protein used in commercial radioassays for vitamin~2 estimation was intrinsic factor con-consistent with the patient's diagnosis in all cases.
In view of current concern over the validity of serum vitamin B 12 results obtained by radioassay and the suggestion that microbiological assay is the only reliable method for this estimation," we present the results of a study in which a commercial radioassay for vitamin B 12 estimations was compared with a radioassay based on that of Tibbling? and also with a microbiological assay. 8
Material and methods
Vitamin B 12 estimations were performed in three independent laboratories by three separate methods. LABORATORY 1 Laboratory 1 used a commercial radioassay kit (Quanta Count Vitamin B 12 Radioassay, Bio-Rad Laboratories, Richmond, California, USA). The kit protocol was followed. After dilution of serum in acid buffer, samples were placed in boiling water for 20 minutes. 57Co-vitamin B 1 2 was added, followed by 'intrinsic factor' binding protein preparation. After incubation excess vitamin B 12 was removed by the addition of an absorbent tablet (of unstated composition), the remains of which was centrifuged out of suspension. The radioactivity in the supernatant fluid was counted in a Packard Autogamma 5210 gamma counter. Normal range for this method was 300-1100 ng/I with a 'borderline' interpretative region of 200-300 ngll. Reproducibility from three months' quality control data was 369 ± 28'7 (mean ± 1 SD), CV = 7'8%.· LABORATORY 2 Laboratory 2 used the radioassay method of Tibbling.? In brief, test samples were diluted in acetate buffer and, after addition of 57Co-vitamiñ 2' were autoclaved. After cooling and centrifuging the supernatant fluid was decanted into counting tubes and allowed to stand for 90 minutes after the addition of diluted normal serum. Bound vitamin B 12 was removed by addition of DE-II cellulose (Whatman), the cellulose pellet being washed twice and then counted in a Searle model 1015 gamma counter. Normal range for this method was 200-850 ngll with a 'borderline' interpretative region of 130-200 ngll. Reproducibility from three months' quality control data was 216 ± 19· 0 (mean ± 1 SD), CV = 8·8%.
*This kit has now been superseded by Quanta-Count Mark 2, which was produced in response to Kolhouse and coworkers' publication.' The manufacturer claims that this new kit does not suffer from the non-specificity shown by the earlier kit since the 'R'-binding component of the binding protein preparation has been saturated with cobinamides. This leaves only the intrinsic factor component free to take part in the assay.
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LABORA TOR Y 3 Laboratory 3 used the microbiological method of Anderson," except that commercial growth media were used. Briefly, equal volumes of diluted test serum and double-strength medium were mixed and heated in a boiling water bath for 15 minutes. After cooling, one drop of a dilute inoculum of Euglena gracilis z-strain was added. The assays were then incubated at 28' 50 for four to five days under fluorescent lighting, after which the absorbance of the resulting suspensions was measured in a Unicam SP 300 colorimeter with a red filter. The normal range for this method depended on the growth medium used. For the major part of this study, B 12 Basal Broth (Becton Dickinson and Co, Cockeysville, Maryland, USA). was used, and a normal range of 200-850 ngll was found with a 'borderline' interpretative range of 130-200 ngll. Withdrawal of this medium from the market led to the substitution of Difco Euglena B 12 medium (Difco Laboratories, Detroit, USA). and re-evaluation of the normal range gave the values 150-850 ngll with a 'borderline' interpretative range of 100-150 ngll. Reproducibility from three months' quality control data was 380 ± 32·9 (mean ± 1 SD), CV = 8'6%.
Laboratory 3 also established the TC II-based radioassay of Tibbling,? as used by laboratory 2.
SAMPLES FOR ANALYSIS
These were all sent initially to one of the three laboratories as routine pathology service specimens. Additional clinical data were obtained from patients' case notes at a later date. Normal results on five serum samples, produced using the commercial kit method in laboratory 1, were judged to be erroneous after the laboratory had been alerted by the clinical staff that the results were at variance with other laboratory tests and clinical symptoms of vitamin B 12 deficiency in the patients. The original serum. samples were then re-analysed by the commercial kit method in laboratory I and were also sent to laboratory 2 for analysis by their TC II-based radioassay. The results produced initiated the rest of this study (see Table I ).
In a separate study, 49 specimens, which had previously been assayed as having a vitamin B 12 content of 350 ngll or less by the TC II-based radioassay of laboratory 2, were re-assayed in all laboratories, laboratory 3 using its microbiological procedure.
Data were also collected over a three-year period in laboratory 3, in which every sample that gav~a result of 320 ngll or less by the TC-I1 based radioassay was re-analysed by the microbiological method. Over 1000 samples were thus analysed. 
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The results from the analysis of serum vitamin B 12 concentrations in five patients with clinical evidence of pernicious anaemia are shown in Table 1 . The test results were initially produced by commercial radioassay in laboratory 1, but these clearly did not indicate the severity of the patients' vitamin B 12 deficiency. Repeat analyses on the same serum samples were then performed in laboratory 2 using their TC II-based radioassay. Results consistent with the clinical diagnosis were obtained in each case.
Comparison of the results of analyses performed in the three laboratories on a separate 49 serum samples is shown in Figure I , All samples selected had initially been analysed as having a vitamin B 1 2 content of 350 ngll or less by the TC II-based radioassay of laboratory 2. This upper limit for vitamin B l 2 content was arbitrarily selected since the misdiagnosis of vitamin B 1 2 deficiency, caused by interference with the radioassay by cobalamin analogues, is most likely to occur in this group of samples. Ofthe 49 specimens, 45 have a normal vitamin B 1 2 result when analysed by the commercial radioassay method. Three samples gave borderline results, and only one gave a value consistent with vitamin B 1 2 deficiency. This is in marked contrast to the microbiological assay results, in which nine samples had unequivocally low vitamin B 1 2 con- Fig. 1 Comparison of vitamin B n analysis results obtained on 49 serum samples with vitamin B n content of 350 ng]] or less by TC Il-based radioassay, Laboratory 1 used a commercial 'intrinsic factor' based radioassay, laboratory 2 used a TC Il-based radioassay, and laboratory 3 used a microbiological assay. The low borderline interpretative range for each method is cross-hotched. Note: The interpretative ranges for the microbiological assay in this series of results were obtained using Difco Euglena B n growth medium and are different from those quoted in Table 2 and Fig. 2 where B IO Basal Broth was used (see Material and methods).
centrations and three had borderline low concentrations. The TC II-based radioassay similarly showed eight samples to be vitamin B 12 deficient, four giving borderline results.
The vitamin B 12 deficient sample detected by the commercial radioassay (78 ng/l) was also detected by the microbiological assay (0 ngjl) and the TC IIbased radioassay « 10 ng/l). The three samples giving borderline low results by the commercial radioassay (285, 295, and 237 ng/l) were unequivocally vitamin B 12 deficient by microbiological assay (90, 45 and 85 ngll) and by TC II-based radioassay (125, 81, and 110 ng/l).
Of the eight remaining discrepant results, four indicated normal serum vitamin 8 12 concentrations by the commercial radioassay (310, 364, 346, and 324 ng/I) but were unequivocally vitamin 8 12 deficient by microbiological assay (75, 90, 80, and 70 ng/I) and by TC II-based radioassay (92, 125, 116, and 106 ng/I). Three vitamin 8 12 results by commercial radioassay (574, 349, and 345 ng/I) were obtained on samples giving borderline low vitamiñ 2 results by microbiological assay (110, 120, and 120 ng/I) and by TC II-based radioassay (174, 181, and 190 ngfl) . One sample gave a normal result by commercial radioassay (582 ng/I) but was vitamin 8 12 deficient by microbiological assay (60 ng/I) and borderline by TC II-based radioassay (130 ng/l), All other results indicated normal serum vitamin 8}2 concentrations by all three methods.
It was noted that TC II-based radioassay gave results that were diagnostically consistent with the microbiological assay.
In an extended study over a three-year period, all routine serum samples entering laboratory 3 for vitamin 8}2 analysis were analysed by their TC II-based radioassay procedure. Any sample that produced a result of less than 320 ng/I was reassayed by their microbiological technique. This group of samples would include almost all those at greatest risk of misdiagnosis of vitamin 8 12 deficiency. Table 2 shows the results of analyses of 792 samples from this series, categorised according to diagnostic interpretation of the result. In 578 (73,0%) of these analyses there was complete agreement in diagnostic interpretation between the results produced by the TC It-based radioassay and the microbiological assay in all diagnostic categories. Of the remainder, 211 (26'6%) samples gave results that were one diagnostic category different by microbiological assay from that by TC II-based radioassay, for example, 49 samples gave results that were diagnostically normal by microbiological assay but diagnostically borderline Figure 2 shows the results from the last 267 samples (approximately nine months) in this series. No major diagnostic or interpretative discrepancies were found between the results of the TC II-based radioassay and the microbiological assay in these samples. Interference with the radioassay of serum vitamin 8}2 concentrations by cobalamin analogues has been amply reported by other authors.P 5 All radioassays subject to this interference used impure preparations of intrinsic factor as the assay binding
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protein," the contaminating 'R' binders reacting with cobalamin analogues as well as cobalamins in patients' sera. If the proposed mechanism of Kolhouse et aP is accepted, then serum samples from vitamin B 1 2 deficient patients that contain sufficient quantities of cobalamin analogues give normal or borderline low results on analysis.P:"
The recognition of this potential error in what has been considered a diagnostic test has led to scepticism over the vitamin B 1 2 results produced by radioassay." Most commercial producers of radioassay kits have responded by issuing a binding protein preparation in which the unsaturated 'R' binder capacity is blocked by the addition of a large excess of cobinamides, so leaving only the intrinsic factor component free to take part in the assay. A few manufacturers have purified their intrinsic factor preparations to free them from 'R' binder contaminants. It is, however, too soon to have any long-term evaluation of either of these modifications from routine diagnostic laboratories.
The transcobalamins of diluted normal human serum were used as the vitamin B 12 binding pro'tein in a radioassay procedure published by Tibbling.? Of the three transcobalamins in serum, transcobalamins I (TC I) and III (TC Ill) are 'R' binder proteins'? of the type found in commercial preparations of intrinsic factor. However, these two binding proteins are present in lower molar concentrations than TC II, and much of their binding capacity is occupied by endogenous vitamin B 12 10 11 and probably by natural cobalamin analogues. Of the unsaturated cobalamin binding capacity of normal serum, approximately 80 % resides with It is the TC II, therefore, that acts as the principal vitamin B 1 2 binding protein in the radioassay of Tibbling.? TC II has been shown to have a much lower affinity for synthetic cobalamin analogues than for cobalarnins.P The results presented here indicate that the affinity of TC II for naturally occurring cobalamin analogues is also sufficiently low for a valid radioassay for vitamin B 12 to be based on this binding protein.
The small proportion of cobalamin binding capacity in diluted normal serum that is due to TC I and TC III (approximately 20 %) might be expected to produce some error in Tibbling's radioassay? by reacting with naturally occurring cobalamin analogues in test samples." To some small extent this may occur since the results in Fig 2 and Table 2 show a slight bias towards higher values for serum vitamin B 1 2 concentrations by TC II-based radioassay when compared with microbiological assay (TC II-based radioassay mean of 267 results shown in Fig 2, = 213 ± 64'9; microbiological assay mean = 204 ± 67·5 (± I SO)). However, it is equally apparent that this minor bias in results is diagnostically insignificant.
As a more definitive test of the specificity of TC 11based radioassay, 49 samples with diagnostically lower normal, borderline, or low vitamin B 1 2 content were analysed independently in our three laboratories, each laboratory using its established routine method. Of these 49 samples, eight gave results by commercial radioassay that were diagnostically at variance with the microbiological assay results. Such analytical discrepancies formed part of the original observations, which suggested the presence of significant concentrations of inactive cobalamin analogues in serum." In each of these eight cases the results of the TC II-based radioassay agreed with the microbiological assay rather than with the commercial radioassay, giving a correct diagnosis of vitamin B 12 deficiency in the samples and implying a specificity for cobalamins in the TC II-based radioassay that is not compromised by the presence of cobalamin analogues. Data supporting the specificity of the TC II-based radioassay were also provided in a recent quality control survey by the Royal College of Pathologists of Australia." All those laboratories using the TC II-based radioassay of Tibbling 7 correctly analysed a vitamin B 12 deficient sample which had high concentrations of naturally occurring cobalamin analogues.P The correct interpretation of this sample was achieved in only 0-60 % of laboratories using commercial intrinsic factor based radioassays, depending on the assay kit used.
Of course, the only real test of the diagnostic accuracy of any serum vitamin B 1 2 assay is that it can distinguish unerringly between patients with and without pernicious anaemia. The results shown in Table 1 confirm the diagnostic accuracy of the TC 11based radioassay in five patients misdiagnosed by a less specific commercial assay. For the rest of the data, results from the TC II-based radioassay have been compared with a microbiological assay. It has never been suggested that the microbiological assay of vitamin B 12 is other than diagnostically accurate in all groups of patients.
Consistent diagnostic agreement between the vitamin B 12 results produced by a TC II-based radioassay and a microbiological method has been found in a three-year study involving all samples with lower normal, borderline low, or vitamin B 12 deficient results entering one of our laboratories as routine diagnostic service specimens. This population of samples would include most of those susceptible to misdiagnosis of vitamin B 12 status if a less specific radioassay were to be used." 6 These findings therefore also argue in favour of the diagnostic accuracy of the TC II-based radioassay.
As a vitamin B 12 binding reagent in vitamin B 12 radioassay, TC II has some advantages over the commonly used intrinsic factor. TC II is readily and cheaply available in large quantities in all laboratories that handle serum or plasma samples. Furthermore, it is considerably easier to purify than intrinsic factor. A single ammonium sulphate precipitation is all that is required to separate TC I and TC III from the TC II. ll It is, however, the experience in two of our laboratories that such a purification of TC II has no significant effect on the diagnostic performance of the radioassay, and it should be noted that all, results reported here for the TC 11based radioassay were obtained using diluted normal serum without further purification of the vitamin B:i2 binding proteins. Finally, TC II is unlikely to interact with intrinsic factor antibodies which are present in most samples from patients with pernicious anaemia. Intrinsic factor antibodies are not completely destroyed in the initial boiling step of vitamin~2 radioassay (RGR, unpublished observations) . A proportion of these remain active against intrinsic factor although the extent of their interference with results from intrinsic factor based radioassays has not been determined. The use of TC II as the vitamin B 12 binding protein avoids this problem while still allowing for a specific radioassay for vitamin B 12 , particularly in that group of patients for whom an accurate result is most diagnostically important.
